Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for Gossamer Bio in a research note issued on ...

Stock analysts at HC Wainwright dropped their Q1 2025 earnings estimates for shares of Gossamer Bio in a note issued to investors on Tuesday, March 18th. HC Wainwright analyst P. Trucchio now ...

周二，H.C. Wainwright重申对Gossamer Bio ...

生物制药公司Gossamer Bio (NASDAQ: GOSS )在发布好于预期的第四季度业绩报告并更新其肺动脉高压药物候选者seralutinib的进展后，股价上涨5.4%。 公司第四季度每股亏损0.15美元，优于分析师预期的每股亏损0.17美元。营收达到934万美元，超过了702万美元的市场预期。

GOSSAMER BIO ($GOSS) is expected to release its quarterly earnings data on Friday, March 21st after market close, per Finnhub. Analysts are expecting revenue of ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Gossamer Bio ( ($GOSS) ) has released its Q4 earnings. Here is a breakdown of the information Gossamer Bio presented to its investors. Gossamer ...

The Kern County Coroner’s Office has identified a man killed after a crash on Gossamer Grove Boulevard as 22-year-old Luis ...

EDT Gossamer Bio (GOSS) reports Q4 revenue $9.4M, consensus $7.0MLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $294.5 million. As a result, we expect our ...